Mabcampath

MabCampath is used to treat patients with B-cell chronic lymphocytic leukaemia (B-CLL), a cancer of a type of white blood cell called B lymphocytes. MabCampath is used in patients for whom treatment combinations including fludarabine (another medicine used in leukaemia) are not appropriate. The medicine can only be obtained with a prescription.

• Medicine Name: Mabcampath
• Generic Name: Alemtuzumab
• Approval Date: 2001
• Company Name: Genzyme Corporation
• Available as (Form & Strength): 30 mg/1 mL single use vial